uniQure Announces Financial Results For Third Quarter 2016 and Provides Update on Company Progress

Go back to uniQure Announces Financial Results For Third Quarter 2016 and Provides Update on Company Progress

Jefferies Downgrades uniQure BV (QURE) to Hold

November 22, 2016 9:46 AM EST

Jefferies downgraded uniQure BV (NASDAQ: QURE) from Buy to Hold with a price target of $8.00 (from $28.00) on execution risk and lack of major near-term catalysts.

Analyst Eun Yang commented, "Once viewed as the most advanced gene therapy platform company (& landmark gene... More